Immix Biopharma, Inc (IMMX) News Headlines

▮ More

Date

Headline

1/4/2023 6:20:24 AM Hadasit And BIRAD Enter Research And License Agreement With Immix BioPharma

12/14/2022 10:21:29 AM Immix Shares Spike After Announcing In-licensing Of NXC-201 With Positive Overall Response

6/2/2022 6:58:13 AM Pre-market Movers: BCAN, IMMX, AI, IBRX, RPTX…

5/20/2022 9:02:43 AM ImmixBio: IMX-110 Shows Improved Survival In Connective Tissue Cancer Soft Tissue Sarcoma Mice Study

2/1/2022 10:50:59 AM Immix Biopharma Rises On Scale-up Manufacturing Of IMX-110 Under GMP

1/12/2022 10:28:54 AM Immix Biopharma Spikes After IMX-110 Surpasses Standard Of Care In Mice Model

1/4/2022 10:30:02 AM Immix Biopharma Gains 25% As Its Pediatric Cancer Treatment Gets FDA's RPD Designation

1/4/2022 7:33:23 AM Pre-market Movers: IMMX, VALN, LQDA, OSAT, EKSO…

1/3/2022 8:49:57 AM Immix Says FDA Grants Rare Pediatric Disease Designation For IMX-110 To Treat Rhabdomyosarcoma

1/3/2022 8:28:56 AM FDA Approves Immix Biopharma Rare Pediatric Disease Designation For IMX-110; Stock Surges

12/20/2021 7:25:11 AM Pre-market Movers: SOPA, VRS, ITCI, IMMX, SPRB…

Older Articles